CARMINA 02 (NCT00629616, [12]) is a French phase II multicenter, randomized neoadjuvant trial evaluating side-by-side the efficacy of anastrozole and fulvestrant in postmenopausal patients with non-metastatic ER+/HER2- BC. The gene discussed is ERBB2; the disease is breast cancer.